These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
917 related items for PubMed ID: 24842571
1. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, Scuccimarri R, Berard R, Tse SM, Morishita K, Stringer E, Johnson N, Levy DM, Duffy KW, Cabral DA, Rosenberg AM, Larché M, Dancey P, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Houghton K, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey S, Bruns A, Campillo S, Benseler S, Chédeville G, Schneider R, Yeung R, Duffy CM, ReACCh-Out investigators. Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571 [Abstract] [Full Text] [Related]
4. Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort. Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Huber AM, Oen K, Gerhold K, Feldman BM, Scuccimarri R, Houghton K, Chédeville G, Morishita K, Lang B, Dancey P, Rosenberg AM, Barsalou J, Bruns A, Watanabe Duffy K, Benseler S, Duffy CM, Tucker LB, ReACCh-Out Investigators. J Rheumatol; 2019 Jun; 46(6):628-635. PubMed ID: 30647178 [Abstract] [Full Text] [Related]
5. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children. Tiller G, Buckle J, Allen R, Munro J, Gowdie P, Cox A, Akikusa J. Pediatr Rheumatol Online J; 2018 Nov 09; 16(1):69. PubMed ID: 30413164 [Abstract] [Full Text] [Related]
8. Description of active joint count trajectories in juvenile idiopathic arthritis. Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C. J Rheumatol; 2014 Dec 09; 41(12):2466-73. PubMed ID: 25274882 [Abstract] [Full Text] [Related]
9. Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort. Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Benseler SM, Tucker LB, ReACCh-Out Investigators. J Rheumatol; 2017 Feb 09; 44(2):230-240. PubMed ID: 27980015 [Abstract] [Full Text] [Related]
15. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis. McMahan R, Balfe LM, Greene L. J Manag Care Pharm; 2012 Apr 09; 18(1 Suppl B):1-16. PubMed ID: 22376227 [Abstract] [Full Text] [Related]
16. Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis. Yue X, Huang B, Hincapie AL, Wigle PR, Qiu T, Li Y, Morgan EM, Guo JJ. Paediatr Drugs; 2021 Mar 09; 23(2):171-182. PubMed ID: 33651370 [Abstract] [Full Text] [Related]
18. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology. Arthritis Rheum; 2011 Sep 09; 63(9):2809-18. PubMed ID: 21560116 [Abstract] [Full Text] [Related]